Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

A low carbohydrate diet in type 1 diabetes: clinical experience--a brief report.

Nielsen JV, Jönsson E, Ivarsson A.

Ups J Med Sci. 2005;110(3):267-73.

PMID:
16454166
2.

Day-to-day consistency in amount and source of carbohydrate intake associated with improved blood glucose control in type 1 diabetes.

Wolever TM, Hamad S, Chiasson JL, Josse RG, Leiter LA, Rodger NW, Ross SA, Ryan EA.

J Am Coll Nutr. 1999 Jun;18(3):242-7.

PMID:
10376780
3.

Carbohydrate sources and glycaemic control in Type 1 diabetes mellitus. EURODIAB IDDM Complications Study Group.

Buyken AE, Toeller M, Heitkamp G, Irsigler K, Holler C, Santeusanio F, Stehle P, Fuller JH.

Diabet Med. 2000 May;17(5):351-9.

PMID:
10872533
4.

A low-fat diet improves peripheral insulin sensitivity in patients with Type 1 diabetes.

Rosenfalck AM, Almdal T, Viggers L, Madsbad S, Hilsted J.

Diabet Med. 2006 Apr;23(4):384-92.

PMID:
16620266
6.

Insulin glargine or NPH combined with metformin in type 2 diabetes: the LANMET study.

Yki-Järvinen H, Kauppinen-Mäkelin R, Tiikkainen M, Vähätalo M, Virtamo H, Nikkilä K, Tulokas T, Hulme S, Hardy K, McNulty S, Hänninen J, Levänen H, Lahdenperä S, Lehtonen R, Ryysy L.

Diabetologia. 2006 Mar;49(3):442-51. Epub 2006 Feb 3.

PMID:
16456680
7.

Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes. A brief report.

Nielsen JV, Jönsson E, Nilsson AK.

Ups J Med Sci. 2005;110(2):179-83.

PMID:
16075898
9.
10.

The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein.

Wolever TM, Gibbs AL, Mehling C, Chiasson JL, Connelly PW, Josse RG, Leiter LA, Maheux P, Rabasa-Lhoret R, Rodger NW, Ryan EA.

Am J Clin Nutr. 2008 Jan;87(1):114-25.

11.

Metformin-pioglitazone and metformin-rosiglitazone effects on non-conventional cardiovascular risk factors plasma level in type 2 diabetic patients with metabolic syndrome.

Derosa G, D'Angelo A, Ragonesi PD, Ciccarelli L, Piccinni MN, Pricolo F, Salvadeo SA, Montagna L, Gravina A, Ferrari I, Paniga S, Cicero AF.

J Clin Pharm Ther. 2006 Aug;31(4):375-83.

PMID:
16882108
12.

Glycemic control in patients with type 2 diabetes mellitus with a disease-specific enteral formula: stage II of a randomized, controlled multicenter trial.

Pohl M, Mayr P, Mertl-Roetzer M, Lauster F, Haslbeck M, Hipper B, Steube D, Tietjen M, Eriksen J, Rahlfs VW.

JPEN J Parenter Enteral Nutr. 2009 Jan-Feb;33(1):37-49. doi: 10.1177/0148607108324582. Epub 2008 Nov 14.

PMID:
19011146
14.

Improved glycemic control and lower frequency of severe hypoglycemia with insulin detemir; long-term experience in 105 children and adolescents with type 1 diabetes.

Braun D, Konrad D, Lang-Muritano M, Schoenle E.

Pediatr Diabetes. 2008 Aug;9(4 Pt 2):382-7. doi: 10.1111/j.1399-5448.2008.00371.x. Epub 2008 Mar 5.

PMID:
18331413
15.

Sustained beneficial metabolic effects 18 months after a 30-day very low calorie diet in severely obese, insulin-treated patients with type 2 diabetes.

Jazet IM, de Craen AJ, van Schie EM, Meinders AE.

Diabetes Res Clin Pract. 2007 Jul;77(1):70-6. Epub 2006 Nov 28.

PMID:
17134786
16.

The metabolic effects of long term exercise in Type 2 Diabetes patients.

Cauza E, Hanusch-Enserer U, Strasser B, Kostner K, Dunky A, Haber P.

Wien Med Wochenschr. 2006 Sep;156(17-18):515-9.

PMID:
17041809
17.

Long-term effects of a diet loosely restricting carbohydrates on HbA1c levels, BMI and tapering of sulfonylureas in type 2 diabetes: a 2-year follow-up study.

Haimoto H, Iwata M, Wakai K, Umegaki H.

Diabetes Res Clin Pract. 2008 Feb;79(2):350-6. Epub 2007 Nov 5.

PMID:
17980451
18.

Efficacy, safety and acceptability of biphasic insulin aspart 30 in Indian patients with type 2 diabetes: results from the PRESENT study.

Sharma SK, Joshi SR, Kumar A, Unnikrishnan AG, Hoskote SS, Moharana AK, Chakkarwar PN, Vaz JA; PRESENT Study Group.

J Assoc Physicians India. 2008 Nov;56:859-63.

PMID:
19263683
19.

Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes.

Kølendorf K, Ross GP, Pavlic-Renar I, Perriello G, Philotheou A, Jendle J, Gall MA, Heller SR.

Diabet Med. 2006 Jul;23(7):729-35.

PMID:
16842476
20.

Supplemental Content

Support Center